The patient is participating in another study
The patient is in an exclusion period determined by a previous study
The patient or his/her representative refuses to sign the consent
It is impossible to correctly inform the patient or his/her representative
The patient is pregnant or breastfeeding
The patient has a contraindication (or an incompatible drug association) for a treatment used in this study
The patient had a coronary stent for less than 12 months
The patient does not require treatment with aspirin or any other antiplatelet agent
The patient has a history of aspirin allergy
High bleeding risk; such as platelets <50,000 / mm3 during screening, Hb <8.5 g / dL, history of intracranial hemorrhage or subdural hematoma, major surgery, parenchymal organ biopsy or severe trauma within 30 days before inclusion, active gastrointestinal ulcer in the last 3 months;
History of Stroke in the last 3 months;
Moderate or severe liver affection associated with coagulopathy
Active infectious endocarditis
Active tumor treated at the time of inclusion associated with expected survival less than one year

NCT02735902_exc_T6
Condition
contraindication
NCT02735902_exc_T8
Device
coronary stent
NCT02735902_exc_T9
Temporal
less than 12 months
NCT02735902_exc_T10
Drug
aspirin
NCT02735902_exc_T11
Condition
allergy
NCT02735902_exc_T12
Observation
bleeding risk
NCT02735902_exc_T13
Qualifier
High
NCT02735902_exc_T14
Measurement
platelets
NCT02735902_exc_T15
Value
<50,000 / mm3
NCT02735902_exc_T16
Measurement
Hb
NCT02735902_exc_T17
Value
<8.5 g / dL
NCT02735902_exc_T18
Condition
intracranial hemorrhage
NCT02735902_exc_T19
Condition
subdural hematoma
NCT02735902_exc_T20
Procedure
major surgery,
NCT02735902_exc_T21
Procedure
parenchymal organ biopsy
NCT02735902_exc_T22
Condition
trauma
NCT02735902_exc_T23
Qualifier
severe
NCT02735902_exc_T24
Temporal
within 30 days
NCT02735902_exc_T25
Qualifier
active
NCT02735902_exc_T26
Condition
gastrointestinal ulcer
NCT02735902_exc_T27
Temporal
last 3 months
NCT02735902_exc_T28
Scope
intracranial hemorrhage or subdural hematoma, major surgery, parenchymal organ biopsy or severe trauma
NCT02735902_exc_T30
Scope
platelets <50,000 / mm3 during screening, Hb <8.5 g / dL, history of intracranial hemorrhage or subdural hematoma, major surgery, parenchymal organ biopsy or severe trauma within 30 days before inclusion, active gastrointestinal ulcer in the last 3 months
NCT02735902_exc_T29
Negation
not
NCT02735902_exc_T31
Mood
require
NCT02735902_exc_T32
Procedure
treatment
NCT02735902_exc_T33
Drug
aspirin
NCT02735902_exc_T34
Drug
antiplatelet agent
NCT02735902_exc_T35
Qualifier
other
NCT02735902_exc_T36
Scope
aspirin or any other antiplatelet agent
NCT02735902_exc_T37
Observation
history of
NCT02735902_exc_T38
Observation
History of
NCT02735902_exc_T39
Condition
Stroke
NCT02735902_exc_T40
Temporal
in the last 3 months
NCT02735902_exc_T41
Qualifier
Moderate
NCT02735902_exc_T42
Qualifier
severe
NCT02735902_exc_T43
Condition
liver affection
NCT02735902_exc_T44
Qualifier
associated with coagulopathy
NCT02735902_exc_T45
Condition
coagulopathy
NCT02735902_exc_T46
Scope
Moderate or severe
NCT02735902_exc_T47
Qualifier
Active
NCT02735902_exc_T48
Condition
infectious endocarditis
NCT02735902_exc_T49
Temporal
Active
NCT02735902_exc_T50
Qualifier
Active
NCT02735902_exc_T51
Temporal
Active
NCT02735902_exc_T52
Condition
tumor
NCT02735902_exc_T53
Procedure
treated
NCT02735902_exc_T54
Temporal
at the time of inclusion
NCT02735902_exc_T55
Measurement
expected survival
NCT02735902_exc_T56
Value
less than one year